The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc's opioid painkiller Roxicodone, saying some parts of the company's application need further evaluation.
from Reuters: Health News https://ift.tt/2Gg4r8f
No comments:
Post a Comment